Breaking News

You are here » Indian-Commodity  :  Top News  :  Suven Life Science secures product patent in Canada

03-Apr2018

Suven Life Science secures product patent in Canada

Suven Life Sciences has secured one product patent from Canada corresponding to the New Chemical Entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases and this Patent is valid through 2033.

The granted claims of the patents include the class of selective 5-HT4 compound and is being developed as therapeutic agents for the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.


Related News

View all news

Crude oil futures end lower on Tuesday

Crude oil futures ended lower on Tuesday with benchmark finishing at its lowest in over a year, as investor attention remained fixed on supply ahead of a key meeting of major oil producers early next month.......

Gold futures end tad lower on Tuesday

Gold futures ended marginally lower on Tuesday, retreating from four-day winning streak, owing to a firmer US currency amid better than expected US housing data. Meanwhile, investors were cautious as they......

Copper futures end lower as world stocks fall

Copper futures ended lower on Tuesday, as world stock markets fell in a tech-led sell-off, while the dollar index rallied from a two-week low, making commodities priced in the greenback more expensive......

Top News

View all news

Megastar Foods planning to incorporate subsidiary

Megastar Foods is planning to incorporate a subsidiary Company. The meeting of the Board of Directors of the company is scheduled to be held on November 27, 2018, to consider the same. Megastar Foods is......

Lupin launches generic Tetrabenazine Tablets

Lupin has launched Tetrabenazine Tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin's Tetrabenazine Tablets, 12.5 mg and 25......

UPL's arm signs definitive agreement to acquire entire stake of IBC

UPL's wholly owned subsidiary-- UPL Corporation, Mauritius has signed a definitive agreement to acquire directly or through its subsidiaries 100% of the shares of INDUSTRIAS BIOQUIM CENTROAMERICANA, SOCIEDAD......